Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown133%
completed133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Metabolism and Sleep Apnea Treatment

NCT05539716
completednot_applicable

CPAP to Treat Cognitive Dysfunction in MS

NCT02544373
unknownphase_1

Effects of Positive Airway Pressure (PAP) in Children With Obstructive Sleep Apnea (OSA)

NCT01156649

Clinical Trials (3)

Showing 3 of 3 trials
NCT05539716Not Applicable

Metabolism and Sleep Apnea Treatment

Recruiting
NCT02544373Not Applicable

CPAP to Treat Cognitive Dysfunction in MS

Completed
NCT01156649Phase 1

Effects of Positive Airway Pressure (PAP) in Children With Obstructive Sleep Apnea (OSA)

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3